SUBSCRIBE
SUBSCRIBE
News   Business

Sorin Group S.p.A. Reports Final Consolidated Results for 2009 and Presents 2010-2014 Strategic Plan

March 19, 2010 | 
1 min read
MILAN, Italy--(BUSINESS WIRE)--Sorin (MIL:SRN): The Board of Directors of Sorin S.p.A., meeting today under the chairmanship of Rosario Bifulco, approved the 2009 financial statements and the Strategic Plan for the 2010-2014 period.
Earnings Europe
MORE ON THIS TOPIC
Business people shaking hand in China.
China
Hengrui Licenses Heart Disease Drug to US Startup for up to $1B+
September 5, 2025
 · 
2 min read
 · 
Tristan Manalac
Concept art for large layoffs showing a line of blocks a cliff
Layoffs
AC Immune Downsizes by 30%, Narrows Pipeline Focus
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Cairo, Egypt, October 31 2024: Novartis CO building in Egypt, Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland, manufactures the drugs
Cardiovascular disease
Novartis Doubles Down on Argo Pact With Fresh $5.2B Commitment
September 3, 2025
 · 
2 min read
 · 
Tristan Manalac
Building a rocket. Halftone hands assemble a rocket shaped puzzle. Concept of a startup, new business. Hasty rocket launch. Innovation, teamwork, development of ideas and technologies
Deals
Vertex, Enlaza Declare War on Autoimmune Disease in Potential $2B+ Pact
September 2, 2025
 · 
2 min read
 · 
Heather McKenzie